About Lykos
Lykos is a company based in San Jose (United States) founded in 2014.. Lykos has raised $315.1 million across 2 funding rounds from investors including Helena, Steveandalex and Vine Ventures. Lykos offers products and services including Midomafetamine Capsules. Lykos operates in a competitive market with competitors including GH Research, Small Pharma and Ketabon, among others.
- Headquarter San Jose, United States
-
Sectors
Government & Social SectorHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$315.1 M (USD)
in 2 rounds
-
Latest Funding Round
$100 M (USD), Series A
Jan 05, 2024
-
Investors
Helena
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lykos
Lykos offers a comprehensive portfolio of products and services, including Midomafetamine Capsules. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Investigational treatment for PTSD using psychedelic compounds
Funding Insights of Lykos
Lykos has successfully raised a total of $315.1M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $100 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $100.0M
-
First Round
First Round
(15 Sep 2023)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Series A - Lykos | Valuation | Helena | |
| Sep, 2023 | Amount | Series A - Lykos | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lykos
Lykos has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Helena, Steveandalex and Vine Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are directed toward early-stage technology companies.
|
Founded Year | Domain | Location | |
|
Venture capital firm supporting AI founders through investments and community.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lykos
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lykos
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lykos Comparisons
Competitors of Lykos
Lykos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GH Research, Small Pharma and Ketabon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for mental disease management are developed using 5-MeO-DMT formulations.
|
|
| domain | founded_year | HQ Location |
Psychedelic-based therapeutics for mental health conditions are developed.
|
|
| domain | founded_year | HQ Location |
Develops innovative therapeutics for treatment-resistant depression.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lykos
Frequently Asked Questions about Lykos
When was Lykos founded?
Lykos was founded in 2014 and raised its 1st funding round 9 years after it was founded.
Where is Lykos located?
Lykos is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Who is the current CEO of Lykos?
Amy Emerson is the current CEO of Lykos.
Is Lykos a funded company?
Lykos is a funded company, having raised a total of $315.1M across 2 funding rounds to date. The company's 1st funding round was a Series A of $215.1M, raised on Sep 15, 2023.
What does Lykos do?
Founded in 2014 and based in San Jose, United States, Lykos operates in the biotechnology sector focused on mental health treatments. Therapeutics are developed to address conditions such as post-traumatic stress disorder through a combination of MDMA capsules, psychological interventions, and supportive services. Operations emphasize clinical development and integration of pharmacological and therapeutic approaches for patient care.
Who are the top competitors of Lykos?
Lykos's top competitors include GH Research, Small Pharma and Ketabon.
What products or services does Lykos offer?
Lykos offers Midomafetamine Capsules.
Who are Lykos's investors?
Lykos has 8 investors. Key investors include Helena, Steveandalex, Vine Ventures, True Ventures, and Unlikely Collaborators Foundation.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.